High-purity lyophilized powders and active pharmaceutical ingredients manufactured under international cGMP compliance.
Exploring the biochemical mechanics, scale-up synthesis engineering, and market shift toward high-dose 1000mg Nicotinamide Adenine Dinucleotide formulations.
Nicotinamide Adenine Dinucleotide (NAD+) serves as an essential coenzyme present in all living cells, functioning as a vital electron acceptor and donor in cellular bioenergetics, mitochondrial oxidative phosphorylation, glycolysis, and the citric acid cycle. Beyond metabolic energy transfer, NAD+ acts as a critical substrate for sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and CD38/CD157 ectoenzymes which dictate genomic stability, DNA repair, chromatin remodeling, and systemic inflammatory modulation.
As organisms age, endogenic NAD+ pools undergo exponential decline—dropping by up to 50% every 20 years due to inflammatory CD38 upregulation and chronic DNA damage activation of PARP1. This systemic deficit has converted NAD+ from a niche biochemical research molecule into a cornerstone therapeutic target for metabolic restoration, neuroprotection, and cellular longevity interventions globally.
Legacy low-dose dietary supplements (50mg–100mg) fail to achieve therapeutic plasma thresholds required to saturate NAD+ salvage pathways in tissue systems. OEM NAD+ 1000mg formulations—specifically lyophilized injectable/infusion vials and advanced liposomal matrices—deliver kinetic concentrations sufficient to overcome hepatic first-pass clearance and activate systemic tissue re-synthesis.
Overcoming structural degradation, stereospecificity barriers, and thermal instability in enterprise-scale manufacturing.
Utilizing dual-enzyme biocatalytic pathways (Nicotinamide phosphoribosyltransferase and Nicotinamide mononucleotide adenylyltransferase), our synthesis yields 100% bioactive β-anomer NAD+ with zero toxic chemical byproducts or unwanted α-anomer isomers.
NAD+ is highly hygroscopic and susceptible to hydrolysis into nicotinamide and ADP-ribose. Our low-temperature vacuum freeze-drying process locks moisture content below 1.5%, ensuring a 24-month shelf life stability at controlled temperatures.
Every batch undergoes rigorous HPLC-MS analysis, heavy metal screening via ICP-MS, residual solvent analysis (ICH Q3C), and kinetic chromogenic LAL assays to guarantee compliance with international pharmacopeial standards.
| Analytical Parameter | Gentolex OEM NAD+ 1000mg Specification | Testing Methodology | Commercial Relevance |
|---|---|---|---|
| Chemical Purity (HPLC) | ≥ 99.5% (β-NAD+ Isomer) | High-Performance Liquid Chromatography | Prevents receptor blockage by inactive α-anomeric impurities. |
| Active Dosage per Vial/Unit | 1000 mg ± 2.5% Target Concentration | Quantitative Gravimetric & Assay Calibration | Fulfills clinical trial and high-dose therapy protocols. |
| Bacterial Endotoxin Content | < 0.005 EU/mg | Kinetic Turbidimetric LAL Method | Essential for parenteral, IV infusion, and sterile re-constitution. |
| Moisture Content (LOD) | ≤ 1.5% Loss on Drying | Karl Fischer Titration | Prevents hydrolytic cleavage during ambient shipping and storage. |
| Heavy Metals Panel | Pb < 0.1 ppm, As < 0.1 ppm, Cd < 0.1 ppm, Hg < 0.05 ppm | ICP-MS (Inductively Coupled Plasma) | Ensures regulatory approval across EU, US FDA, and LATAM markets. |
From bulk API synthesis to finished dosage licensing out, lab setup, and regulatory assistance.
Our main services focus on supplying peptides APIs and Custom Peptides, Finished Dosage Form (FDF) license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions. We empower pharmaceutical enterprises, biotechnology companies, and wellness brands to rapidly deploy high-dose NAD+ products without capital-intensive infrastructure investments.
State-of-the-art sterile liquid filling and freeze-drying in 1000mg and 500mg dosages, compatible with clinical reconstitutions and research applications.
Engineered nano-liposomal encapsulations engineered for maximum oral bioavailability, protecting NAD+ from stomach gastric degradation.
Custom co-formulations integrating NAD+ with mitochondrial-targeting peptides like SS-31, cellular repair pentadecapeptides (BPC-157), and metabolic modifiers.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions. Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Exploring recent developments in neuroactive peptides, mitochondrial agents, and API synthesis.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Derived from endogenous tuftsin, it offers profound neuropharmacological stability...
View Details
As a professional Thymosin Beta-4 API manufacturer, we provide high-grade Tβ4 peptide solutions for biotechnology research, tissue repair applications, and global bio-pharma organizations under full cGMP assurance...
View Details
BPC-157 API is a synthetic pentadecapeptide investigated for tissue repair, gastrointestinal mucosal protection, angiogenesis regulation, and joint recovery pathways in specialized longevity research...
View Details
With continuous advancement in neuroscience and peptide synthesis, Semax—a heptapeptide derivative of ACTH(4-10)—remains a benchmark molecule for neuroplasticity and cognitive bio-research...
View Details
SS-31 API (Elamipretide, MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed to selectively bind cardiolipin in the inner mitochondrial membrane, supporting bioenergetics and reducing oxidative strain...
View DetailsExpanding product portfolios with specialized raw materials and lyophilized formulations.
Addressing common queries regarding scale-up synthesis, regulatory dossiers, formulation stability, and B2B ordering.
The 1000mg dosage is engineered to satisfy strict clinical and therapeutic protocols requiring high systemic bioavailability. Low-dose oral forms (50-100mg) are largely degraded by enzymatic enzymes in the digestive tract. A 1000mg lyophilized vial allows health professionals and formulators to prepare precise parenteral infusions or high-concentration formulations that achieve rapid tissue saturation, effectively restoring mitochondrial NAD+/NADH ratios.
We employ a proprietary enzymatic biocatalytic synthesis that mirrors natural cellular metabolic pathways. Unlike harsh chemical synthetic routes that yield a mixture of active β-NAD+ and biologically inactive or toxic α-NAD+ enantiomers, our process stereospecifically synthesizes only the biologically active β-nicotinamide adenine dinucleotide, achieving HPLC purity exceeding 99.5%.
Gentolex provides comprehensive analytical packages with every batch, including Certificate of Analysis (CoA), High-Performance Liquid Chromatography (HPLC) traces, Mass Spectrometry (MS) spectra, Heavy Metal ICP-MS reports, Residual Solvent Analysis (ICH Q3C), and Endotoxin test certifications. Drug Master Files (DMF) and cGMP documentation are available for finished dosage licensing clients.
In its lyophilized powder state with moisture maintained below 1.5%, NAD+ 1000mg remains stable for 24 months when stored at -20°C to 4°C protected from light and humidity. Once reconstituted with sterile bacteriostatic water, liquid solutions should be refrigerated at 2°C-8°C and utilized within controlled clinical timeframes.
Yes. We offer complete OEM/ODM contract manufacturing services. This includes custom vial sizes (20mL, 30mL), specialized stopper siliconization, flip-off cap customization, custom box packaging, barcoding, and private labeling configured to meet your brand's regional compliance rules.
Gentolex has established dedicated regional representative offices in Mexico and South Africa to provide localized customer service, customs clearing support, expedited cold-chain logistics, and regional regulatory guidance. This eliminates timezone barriers and streamlines cross-border customs processes.
